{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:05:32Z","timestamp":1793304332395,"version":"4.5.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1212\/wnl.47.6.1518","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:24:51Z","timestamp":1336915491000},"page":"1518-1523","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":45,"title":["Clozapine-induced myotoxicity in patients with chronic psychotic disorders"],"prefix":"10.1212","volume":"47","author":[{"given":"S. N.","family":"Scelsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. L.","family":"McQuistion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fineman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Reichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"7","volume":"324","year":"1991","unstructured":"Baldessarini RJ, Frankenburg FR. Clozapine: a novel antipsychotic agent. N Engl J Med 1991;324:746-754.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307013290101"},{"key":"e_1_3_1_4_2","first-page":"2","volume":"49","year":"1988","unstructured":"Lieberman JA, Johns CA, Kane JM, et al. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs. J Clin Psychiatry 1988;49:271-277.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561779"},{"key":"e_1_3_1_6_2","first-page":"3","volume":"41","year":"1991","unstructured":"Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology 1991;41:369-371.","journal-title":"Neurology"},{"key":"e_1_3_1_7_2","first-page":"S","volume":"99","year":"1989","unstructured":"Krupp P, Barnes P. Leponex-associated granulocytopenia: a review of the situation. Psychopharmacology 1989;99:S118-S121.","journal-title":"Psychopharmacology"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198601000-00002"},{"key":"e_1_3_1_9_2","first-page":"1","volume":"2","year":"1988","unstructured":"Muller T, Becher T, Fritz J. Neuroleptic malignant syndrome after clozapine plus carbamazepine. Lancet 1988;2:1500.","journal-title":"Lancet"},{"key":"e_1_3_1_10_2","first-page":"9","volume":"52","year":"1991","unstructured":"Miller DD, Sharafuddin MJ, Kathol RG. A case of clozapine-induced neuroleptic malignant syndrome. J Clin Psychiatry 1991;52:99-101.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"2","year":"1990","unstructured":"Nopoulos P, Flaum M, Miller DD. Atypical neuroleptic malignant syndrome (NMS) with an atypical neuroleptic: clozapine-induced NMS without rigidity. Ann Clin Psychiatry 1990;2:251-253.","journal-title":"Ann Clin Psychiatry"},{"key":"e_1_3_1_12_2","first-page":"7","volume":"54","year":"1993","unstructured":"Weller M, Kornhuber J. Does clozapine cause neuroleptic malignant syndrome? J Clin Psychiatry 1993;54:70-71.","journal-title":"Does clozapine cause neuroleptic malignant syndrome? J Clin Psychiatry"},{"key":"e_1_3_1_13_2","first-page":"1","volume":"12","year":"1992","unstructured":"Goates MG, Escobar JI. An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of clozapine therapy: report of a case and results of clozapine rechallenge. J Clin Psychopharmacol 1992;12:139-140.","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000050157"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199502001-00001"},{"key":"e_1_3_1_16_2","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association 1994:273-315."},{"key":"e_1_3_1_17_2","unstructured":"Klaassen CD. Principles of toxicology. In: Gilman AG Rall TW Nies AS Taylor P eds. Goodman and Gilman's: the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press 1990:49-61."},{"key":"e_1_3_1_18_2","first-page":"2","volume":"224","year":"1981","unstructured":"Kissling WR, Ricker K, Pflughaupt KW, et al. Serum myoglobin in primary and secondary muscle disorders. J Neurol 1981;224:229-233.","journal-title":"J Neurol"},{"key":"e_1_3_1_19_2","first-page":"4","volume":"23","year":"1970","unstructured":"Meltzer HY, Moline R. Muscle abnormalities in acute psychosis. Arch Gen Psychiatry 1970;23:481-491.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_20_2","first-page":"4","volume":"23","year":"1970","unstructured":"Meltzer HY, Engel WK. Histochemical abnormalities of skeletal muscle in acutely psychotic patients. Arch Gen Psychiatry 1970;23:492-502.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_21_2","first-page":"5","volume":"23","year":"1970","unstructured":"Fischman DA, Meltzer HY, Poppei RW. Disruption of myofibrils in the skeletal muscle of psychotic patients. Arch Gen Psychiatry 1970;23:503-515.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_22_2","first-page":"7","volume":"23","year":"1973","unstructured":"Meltzer HY, McBride E, Poppei RW. Rod (nemaline) bodies in the skeletal muscle of an acutely psychotic patient. Neurology 1973;23:769-780.","journal-title":"Neurology"},{"key":"e_1_3_1_23_2","first-page":"6","volume":"37","year":"1980","unstructured":"Meltzer HY, Ross-Stanton J, Schlessinger. Mean serum creatine kinase activity in patients with functional psychoses. Arch Gen Psychiatry 1980;37:650-655.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.133.1.1"},{"key":"e_1_3_1_25_2","first-page":"5","volume":"53","year":"1992","unstructured":"Gurrera RJ, Chang SS, Romero J. A comparison of diagnostic criteria for neuroleptic malignant syndrome. J Clin Psychiatry 1992;53:56-62.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.1.1"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000291927"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30269-3"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/249003a0"},{"key":"e_1_3_1_30_2","first-page":"4","volume":"40","year":"1977","unstructured":"Crayton JW, Stalberg E, Hilton-Brown P. The motor unit in psychotic patients: a single fibre EMG study. J Neurol Neurosurg Psychiatry 1977;40:455-463.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_31_2","first-page":"2","volume":"27","year":"1994","unstructured":"Brockmoller J, Roots I. Assessment of liver metabolic function. Clin Pharmacokinet 1994;27:216-248.","journal-title":"Clin Pharmacokinet"},{"key":"e_1_3_1_32_2","unstructured":"Rudorfer MV. Pharmacokinetics of psychotropic drugs in special populations. J Clin Psychiatry 1993;54(suppl):50-56."},{"key":"e_1_3_1_33_2","first-page":"4","volume":"39","year":"1995","unstructured":"Arranz MJ, Dawson E, Shaikh S, et al. Cytochrome P450 2D6 genotype does not determine response to clozapine. Br J Clin Pharmacol 1995;39:417-420.","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_1_34_2","first-page":"9","volume":"272","year":"1995","unstructured":"Pirmohamed M, Williams D, Madden S, Templeton E, Park BK. Metabolism and bioactivation of clozapine by human liver in vitro. J Pharmacol Exp Ther 1995;272:984-990.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_35_2","first-page":"1","volume":"260","year":"1992","unstructured":"Fischer V, Vogels B, Maurer G, Tynes RE. The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6. J Pharmacol Exp Ther 1992;260:1355-1360.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2740001"},{"key":"e_1_3_1_37_2","first-page":"2","volume":"31","year":"1982","unstructured":"Weiss B, Prozialeck WC, Wallace TL. Commentary: interaction of drugs with calmodulin: biochemical, pharmacological and clinical implications. Biochem Pharmacol 1982;31:2217-2226.","journal-title":"Biochem Pharmacol"},{"key":"e_1_3_1_38_2","unstructured":"Perry SV. Activation of the contractile mechanism by calcium. In: Engel AG Franzini-Armstrong C eds. Myology. 2nd ed. New York: McGraw-Hill 1994:529-549."},{"key":"e_1_3_1_39_2","first-page":"5","volume":"79","year":"1983","unstructured":"Wong ET, Cobb C, Umahara MK. Heterogeneity of serum CK activity among racial and gender groups of the population. Am J Clin Pathol 1983;79:582-586.","journal-title":"Am J Clin Pathol"},{"key":"e_1_3_1_40_2","first-page":"3","volume":"13","year":"1978","unstructured":"Meltzer HY, Dorus E, Grunhaus L, Davis JM, Belmaker R. Genetic control of human plasma creatine phosphokinase activity. Clin Genet 1978;13:321-326.","journal-title":"Clin Genet"},{"key":"e_1_3_1_41_2","first-page":"4","volume":"151","year":"1987","unstructured":"Dinan TG. Calcium-activated potassium conductance: an alternative to the dopamine hypothesis of neuroleptic action? Br J Psychiatry 1987;151:455-459.","journal-title":"Calcium-activated potassium conductance: an alternative to the dopamine hypothesis of neuroleptic action? Br J Psychiatry"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-197001000-00002"},{"key":"e_1_3_1_43_2","first-page":"4","volume":"4","year":"1984","unstructured":"Thase ME, Shostak M. Rhabdomyolysis complicating rapid intramuscular neuroleptization. J Clin Psychopharmacol 1984;4:46-48.","journal-title":"J Clin Psychopharmacol"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.6.1518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T11:27:50Z","timestamp":1711538870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.6.1518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["10.1212\/WNL.47.6.1518"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.6.1518","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}